CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease
Udayakumar Karunakaran, Nam Ho Jeoung
Diabetes Metab J. 2010;34(4):211-219.   Published online August 31, 2010
DOI: https://doi.org/10.4093/kdj.2010.34.4.211

Excel Download

O-GlcNAc Modification: Friend or Foe in Diabetic Cardiovascular Disease
Korean Diabetes Journal. 2010;34(4):211   Crossref logo
Link1 Link2 Link3

Insulin treatment and cardiovascular disease; friend or foe? A point of view
Diabetic Medicine. 2005;22(2):118-126   Crossref logo
Link1 Link2

NF-κB in transplantation: friend or foe?
Transplant Infectious Disease. 2001;3(4):212-219   Crossref logo
Link1 Link2 Link3

Resource Management: Friend or Foe?
Diabetic Medicine. 1992;9(6):501-502   Crossref logo
Link1 Link2

Coffee: friend or foe for diabetes risk?
Diabetic Medicine. 2014;31(7):763-763   Crossref logo
Link1 Link2

Prokineticin Receptors in Cardiovascular Function: Foe or Friend?
Trends in Cardiovascular Medicine. 2009;19(2):55-60   Crossref logo
Link1 Link2

S-glutathionylation, friend or foe in cardiovascular health and disease
Redox Biology. 2020;37:101693   Crossref logo
Link1 Link2

False Tendon in Cardiovascular Diseases: Friend, Foe, or Bystander?
Journal of Cardiovascular Imaging. 2021;29(1):57   Crossref logo
Link1 Link2 Link3

Tofacitinib in cardiovascular outcomes: friend or foe?
Rheumatology. 2020;59(8):1797-1798   Crossref logo
Link1 Link2

Editorial commentary: Technology to treat heart failure: Friend or foe?
Trends in Cardiovascular Medicine. 2018;28(7):489-490   Crossref logo
Link1 Link2